Stock Fundamentals

Company Information

Company Name
2Seventy Bio Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US9013841070
CIK: 0001860782
CUSIP: 901384107
Currency: USD
Full Time Employees: 65
Phone: 617 675 7270
Fiscal Year End: December
IPO Date: Nov 03, 2021
Description:

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes Abecma, a chimeric antigen receptor T-cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol Myers Squibb Company. 2seventy bio, Inc. was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.

Address:

60 Binney Street, Cambridge, MA, United States, 02142

Directors & Officers

Name Title Year Born
Mr. William D. Baird III, M.B.A. CEO, President & Director 1972
Ms. Victoria Eatwell Chief Financial Officer 1986
Ms. Jessica Snow Chief Operating Officer 1979

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 17, 2025 Jessica Snow N/A Sale 2.30K $4.95 $11.38K
Mar 17, 2025 Victoria Eatwell N/A Sale 2.59K $4.95 $12.83K
Mar 17, 2025 William D Baird III N/A Sale 5.09K $4.95 $25.21K
Mar 11, 2025 Global Healthcare Master Kynam N/A Sale 5.14M $4.93 $25.35M
Dec 13, 2024 Jessica Snow N/A Sale 2.29K $3.23 $7.39K
Nov 18, 2024 Marcela V Maus N/A Sale 3.90K $3.38 $13.18K
Aug 14, 2024 Jessica Snow N/A Sale 7.82K $4.32 $33.77K
Aug 05, 2024 Victoria Eatwell N/A Sale 13.00 $3.98 $51.74

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Goldman Sachs Group Inc 4.68M Mar 31, 2025 8.80% $0.00 9.01%
Beryl Capital Management LLC 4.25M Mar 31, 2025 7.98% $7.84 0.00%
BlackRock Inc 3.97M Mar 31, 2025 7.46% $0.00 -5.94%
Morgan Stanley - Brokerage Accounts 2.97M Mar 31, 2025 5.57% $0.00 1.69%
Vanguard Group Inc 2.82M Mar 31, 2025 5.30% $0.00 -25.04%
Newtyn Management LLC 2.53M Mar 31, 2025 4.76% $1.98 0.00%
Bank of America Corp 2.52M Mar 31, 2025 4.73% $0.00 0.02%
Baker Bros Advisors LP 2.50M Mar 31, 2025 4.69% $0.14 0.00%
Man Group PLC 2.04M Mar 31, 2025 3.84% $0.03 0.00%
Casdin Capital, LLC 2.00M Mar 31, 2025 3.76% $0.81 0.00%
Glazer Capital, LLC 1.33M Mar 31, 2025 2.50% $0.30 0.00%
Regeneron Pharmaceuticals Inc 1.25M Mar 31, 2025 2.36% $0.50 0.00%
Geode Capital Management, LLC 1.21M Mar 31, 2025 2.27% $0.00 2.82%
First Trust Capital Management L.P. 1.14M Mar 31, 2025 2.15% $0.41 0.00%
State Street Corp 1.07M Mar 31, 2025 2.01% $0.00 -0.73%
The Toronto-Dominion Bank 800.00K Mar 31, 2025 1.50% $0.01 0.00%
Engine Capital Management LP 703.97K Mar 31, 2025 1.32% $0.66 0.00%
Madison Avenue Partners, LP 579.90K Mar 31, 2025 1.09% $0.24 0.00%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 460.00K Mar 31, 2025 0.86% $0.00 64.29%
Dafna Capital Management LLC 429.25K Mar 31, 2025 0.81% $0.60 0.00%

Shares Statistics

Shares Outstanding: 53.23M
Shares Float: 42.70M
% Insiders: 643.80%
% Institutions: 8,240.30%
Short % Float: 5.07%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Man Event Driven Alternative IN USD 1.16M 2.18% ▲ 0.00% Mar 31, 2025
2 Fidelity Small Cap Index 498.32K 0.94% ▲ 2.30% Apr 30, 2025
3 Stork Fund Dynamic MultiStrategies O EUR 255.71K 0.48% ▲ 0.00% Mar 31, 2025
4 Galileo - Biotech Innovation Fund S USD 146.70K 0.28% ▲ 0.00% Dec 31, 2024
5 GDL Fund 85.00K 0.16% ▲ 0.00% Mar 31, 2025
6 Northern Trust Extended Eq Market Idx 61.23K 0.12% ▲ 4.67% Mar 31, 2025
7 Northern Trust Russell 2000 Value Index 54.97K 0.10% ▼ 46.27% Mar 31, 2025
8 NT Col R2000 Val Idx Fd -DC -L -TierFour 54.97K 0.10% ▼ 46.27% Mar 31, 2025
9 Fidelity Small Cap Value Index 54.02K 0.10% ▲ 2.74% Apr 30, 2025
10 Russell Personalized DI All Cap SMA 48.41K 0.09% ▲ 0.00% Mar 31, 2025

Valuation Metrics

Enterprise Value: $335.54M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $266.14M
EBITDA: $-52.72M
Book Value: $4.08
Earnings/Share: $-0.08
Profit Margin: -8.46%
Operating Margin: -10.74%
ROA (TTM): -7.49%
ROE (TTM): -1.94%
Revenue (TTM): $48.37M
Revenue/Share (TTM): $0.92
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 84.50%

Stock Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 4.67x 0.08x 0.56x N/A -0.17x
2023-12-31 3.98x 0.05x 0.55x -27.91x -0.06x
2022-12-31 3.77x 0.04x 0.53x -30.88x -0.04x
2021-12-31 2.96x 0.05x 0.53x -1.14x 1.22x
2020-12-31 0.33x 0.41x 0.76x N/A -0.23x
2019-12-31 0.20x 0.52x 0.86x N/A -0.07x
2018-12-31 N/A N/A N/A -13.14x 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about TSVT.US!